<H1>Chapter DOI: 10.1208/aapsj070107<br/>Cited-By Count: 8</H1><table border="1" width="30%"><tr><td>Total References</td><td>39</td></tr><tr><td>Springer references</td><td>0</td></tr><tr><td>Non Springer references</td><td>39</td></tr><tr><td>BibStructured Count</td><td width="10%">34</td></tr><tr><td>BibUnstructured Count</td><td width="10%">5</td></tr><tr><td>DOI already available in SpringerLink</td><td>26</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>5</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>5</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>5</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Hennessey JV. Levothyroxine a new drug? Since when? How could that be?.<Emphasis Type="Italic">Thyroid</Emphasis> 2003;13:279&#8211;282.</td><td><a href=http://dx.doi.org/10.1089/105072503321582088>10.1089/105072503321582088</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Mandel SJ, Brent GA, Larsen PR. Levothyroxine therapy in patients with thyroid disease.<Emphasis Type="Italic">Ann Intern Med.</Emphasis> 1993;119:492&#8211;502.</td><td><a href=http://dx.doi.org/10.7326/0003-4819-119-6-199309150-00009>10.7326/0003-4819-119-6-199309150-00009</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, VolumeID, Year, ArticleTitle, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Singer PA, Cooper DS, Levy EG et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association.<Emphasis Type="Italic">JAMA</Emphasis>. 1995;273:808&#8211;812.</td><td><a href=http://dx.doi.org/10.1001/jama.273.10.808>10.1001/jama.273.10.808</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>AACE Thyroid Task Force. American Association of Clinical endorrinologist medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism.<Emphasis Type="Italic">Endocr Pract.</Emphasis> 2002;8:457&#8211;469.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR5</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>McDermott</span> <span style='background:#DDDDDD'>MT</span></span></aug>. <span style='background:#FFD9B3'>American College of Physicians, Physicians' Information and Education Resource: Hypothyroidism</span>. Available at: <span style='background:#FF3300'>http://pier.acponline</span>. org/physicians/diseases/d238/d238.html.Accessed September 20, <span style='background:#66FF66'>2004</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Pop VJ, Kuijpens JL, van Baar AL, et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy.<Emphasis Type="Italic">Clin Endocrinol (Oxf)</Emphasis>. 1999;50:149&#8211;155.</td><td><a href=http://dx.doi.org/10.1046/j.1365-2265.1999.00639.x>10.1046/j.1365-2265.1999.00639.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid dificiency during pregnancy and subsequent neuropsychological development of the child.<Emphasis Type="Italic">N Engl J Med.</Emphasis> 1999;341:549&#8211;555.</td><td><a href=http://dx.doi.org/10.1056/NEJM199908193410801>10.1056/NEJM199908193410801</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidims.<Emphasis Type="Italic">N Engl J Med.</Emphasis> 2004;351:241&#8211;249.</td><td><a href=http://dx.doi.org/10.1056/NEJMoa040079>10.1056/NEJMoa040079</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease.<Emphasis Type="Italic">Thyroid.</Emphasis> 2003;13:3&#8211;126.</td><td><a href=http://dx.doi.org/10.1089/105072503321086962>10.1089/105072503321086962</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibBook</td><td>Arem R.<Emphasis Type="Italic">The Thyroid Solution</Emphasis>. New York, NY: Ballantine Books; 1999.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ, Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism.<Emphasis Type="Italic">N Engl J Med.</Emphasis> 1999;340:424&#8211;429.</td><td><a href=http://dx.doi.org/10.1056/NEJM199902113400603>10.1056/NEJM199902113400603</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Sawka AM, Gerstein HC, Marriott MJ, MacQueen GM, Joffe RT. Does a combination regiment of thyroxine (T4) and 3,5,3?-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial.<Emphasis Type="Italic">J Clin Endocrinol Metab.</Emphasis> 2003;88:4551&#8211;4555.</td><td><a href=http://dx.doi.org/10.1210/jc.2003-030139>10.1210/jc.2003-030139</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Clyde PW, Harari AE, Getka EJ, Shakir KM. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial.<Emphasis Type="Italic">JAMA.</Emphasis> 2003;290:2952&#8211;2958.</td><td><a href=http://dx.doi.org/10.1001/jama.290.22.2952>10.1001/jama.290.22.2952</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Walsh JP, Shiels L, Lim EM, et al. Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism.<Emphasis Type="Italic">J Clin Endocrinol Metab.</Emphasis> 2003;88:4543&#8211;4550.</td><td><a href=http://dx.doi.org/10.1210/jc.2003-030249>10.1210/jc.2003-030249</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Shimon I, Cohen O, Lubetsky A, Olchovsky D. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism.<Emphasis Type="Italic">Thyroid.</Emphasis> 2002;12:823&#8211;827.</td><td><a href=http://dx.doi.org/10.1089/105072502760339406>10.1089/105072502760339406</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>McGriff NJ, Csako G, Gourgiotis L, Lori CG, Pucino F, Sarlis NJ. Effects of thyroid hormone suppression therapy on adverse clinical out-comes in thyroid cancer.<Emphasis Type="Italic">Ann Med.</Emphasis> 2002;34:554&#8211;564.</td><td><a href=http://dx.doi.org/10.1080/078538902321117760>10.1080/078538902321117760</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Carr D, McLeod DT, Parry G, Thornes HM. Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment.<Emphasis Type="Italic">Clin Endocrinol (Oxf).</Emphasis> 1988;28:325&#8211;333.</td><td><a href=http://dx.doi.org/10.1111/j.1365-2265.1988.tb01219.x>10.1111/j.1365-2265.1988.tb01219.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Lum SM, Nicoloff JT, Spencer CA, Kaptein EM. Peripheral tissue mechanism for maintenance of serum triiodothyronine values in a thyroxine-deficient state in man.<Emphasis Type="Italic">J Clin Invest.</Emphasis> 1984;73:570&#8211;575.</td><td><a href=http://dx.doi.org/10.1172/JCI111245>10.1172/JCI111245</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Nicoloff JT, Lum SM, Spencer CA, Morris R. Peripheral autoregulation of thyroxine to triiodothyronine conversion in man.<Emphasis Type="Italic">Horm Metab Res Suppl.</Emphasis> 1984;14:74&#8211;79.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons.<Emphasis Type="Italic">N Engl J Med.</Emphasis> 1994;331:1249&#8211;1252.</td><td><a href=http://dx.doi.org/10.1056/NEJM199411103311901>10.1056/NEJM199411103311901</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Biondi B, Fazio S, Carella C. et al. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine.<Emphasis Type="Italic">J Clin Endocrinol Metab.</Emphasis> 1993;77:334&#8211;338.</td><td><a href=http://dx.doi.org/10.1210/jc.77.2.334>10.1210/jc.77.2.334</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Mercuro G, Panzuto MG, Bina A, et al. Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring.<Emphasis Type="Italic">J Clin Endocrinol Metab.</Emphasis> 2000;85:159&#8211;164.</td><td><a href=http://dx.doi.org/10.1210/jc.85.1.159>10.1210/jc.85.1.159</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Greenspan SL, Greenspan FS. The effect of thyroid hormone on skeletal integrity.<Emphasis Type="Italic">Ann Intern Med.</Emphasis> 1999;130:750&#8211;758.</td><td><a href=http://dx.doi.org/10.7326/0003-4819-130-9-199905040-00016>10.7326/0003-4819-130-9-199905040-00016</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, VolumeID, Year, ArticleTitle, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Ross DS, Neer RM, Ridgway EC, Daniels GH. Subclinical hyperthyroidism and reduced bone density as a possible results of prolonged suppression of the pituitary-thyroid axis with L-thyroxine.<Emphasis Type="Italic">Am J Med.</Emphasis> 1987;82:1167&#8211;1170.</td><td><a href=http://dx.doi.org/10.1016/0002-9343(87)90219-1>10.1016/0002-9343(87)90219-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Toft AD. Clinical practice. Subclinical hyperthyroidism.<Emphasis Type="Italic">N Engl J Med.</Emphasis> 2001;345:512&#8211;516.</td><td><a href=http://dx.doi.org/10.1056/NEJMcp010145>10.1056/NEJMcp010145</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Solomon BL, Wartofsky L, Burman KD. Prevalence of fractures in postmenopausal women with thyroid disease.<Emphasis Type="Italic">Thyroid.</Emphasis> 1993;3:17&#8211;23.</td><td><a href=http://dx.doi.org/10.1089/thy.1993.3.17>10.1089/thy.1993.3.17</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, Author_FamilyName_1, FirstPage, VolumeID, Year, ArticleTitle, JournalTitle</td><td>CrossRef</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Bauer DC, Ettinger B, Nevitt MC, Stone KL. Risk for fracture in women with low serum levels of thyroid-stimulating hormone.<Emphasis Type="Italic">Ann Intern Med.</Emphasis> 2001;134:561&#8211;568.</td><td><a href=http://dx.doi.org/10.7326/0003-4819-134-7-200104030-00009>10.7326/0003-4819-134-7-200104030-00009</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, ArticleTitle, Year, VolumeID, FirstPage</td><td>CrossRef</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study.<Emphasis Type="Italic">Ann Intern Med.</Emphasis> 2000;132:270&#8211;278.</td><td><a href=http://dx.doi.org/10.7326/0003-4819-132-4-200002150-00004>10.7326/0003-4819-132-4-200002150-00004</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, ArticleTitle, FirstPage, VolumeID, Author_FamilyName_1, Author_FamilyName_2</td><td>CrossRef</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Tunbridge WM, Evered DC, Hall R, et al. Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure.<Emphasis Type="Italic">Clin Endocrinol (Oxf).</Emphasis> 1977;7:495&#8211;508.</td><td><a href=http://dx.doi.org/10.1111/j.1365-2265.1977.tb01341.x>10.1111/j.1365-2265.1977.tb01341.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study.<Emphasis Type="Italic">Arch Intern Med.</Emphasis> 2000;160:526&#8211;534.</td><td><a href=http://dx.doi.org/10.1001/archinte.160.4.526>10.1001/archinte.160.4.526</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994) National Health and Nutrition Examination Survey (NHANES III).<Emphasis Type="Italic">J Clin Endocrinol Metab.</Emphasis> 2002;87:489&#8211;499.</td><td><a href=http://dx.doi.org/10.1210/jc.87.2.489>10.1210/jc.87.2.489</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibUnstructured</td><td>Food and Drug Administration. Center for Drug Evaluation and Research. Guidance for Industry: Levothyroxine Sodium Tablets&#8212;In Vivo Pharmacokinetic and Bioavailability Studies and In Vitro Dissolution Testing. Available at: <span style='background:#FF3300'>http://www.fda.gov/cder/guidance/364 fnl.htm</span>. Accessed March 8, 2000.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Blakesley V, Awni W, Locke C, Ludden T, Granneman GR, Braverman LE. Are bioequivalence studies of levothyroxine sodium formulations in euthyroid volunteers reliable?<Emphasis Type="Italic">Thyroid.</Emphasis> 2004;14:191&#8211;200.</td><td><a href=http://dx.doi.org/10.1089/105072504773297867>10.1089/105072504773297867</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Yu</span> <span style='background:#DDDDDD'>LX</span></span></aug>. <span style='background:#FFD9B3'>Letter to ANDA file: Approval of ANDA 76&#8211;187</span>, <span style='background:#FFFF49'>Mylan Pharmaceuticals Inc</span>, Levothyroxine Sodium Tablets. Available at: <span style='background:#FF3300'>http://www.fda.gov/cder/foi/anda/2002/076187_Bioequiv_Corresp.pdf</span>. Accessed June 5, <span style='background:#66FF66'>2002</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR35</td><td>BibUnstructured</td><td>Food and Drug Administration. Advisory Committe for Pharmaceutical Science. Record of Proceedings. Available at: <span style='background:#FF3300'>http://www.fda.gov/ohrms/dockets/ac/03/transcripts/3926T2.pdf</span>. Accessed November 15, 2004.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR36</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Hubbard</span> <span style='background:#DDDDDD'>WK</span></span></aug>. <span style='background:#FFD9B3'>Request that the Commissioner of Food and Drug take action described methodology for oral levothyroxine sodium drug products: Reply to Petitioners</span>. <span style='background:#FFFF0F'>Available at: http://www.fda.gov/ohrms/dockets/dailys/04/June04/062904/03p-0387-pdn0001-vol5.pdf.Accessed June 23, 2004</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR37</td><td>BibArticle</td><td>American Thyroid Association, The Endocrine Society, American Association of Clinical Endocrinologists. Joint statement on the U.S. Food and Drug Administration's decision regarding bioequivalence of levothyroxine sodium.<Emphasis Type="Italic">Thyroid.</Emphasis> 2004;14:486.</td><td><a href=http://dx.doi.org/10.1089/1050725041517138>10.1089/1050725041517138</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR38</td><td>BibArticle</td><td>Burmeister LA, Goumaz MO, Mariash CN, Oppenheimer JH. Levothyroxine dose requirements for thyrotropin suppression in the treatment of differentiated thyroid cancer.<Emphasis Type="Italic">J Clin Endocrinol Metab.</Emphasis> 1992;75:344&#8211;350.</td><td><a href=http://dx.doi.org/10.1210/jc.75.2.344>10.1210/jc.75.2.344</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR39</td><td>BibArticle</td><td>Oppenheimer JH, Braverman LE, Toft A, Jackson IM, Ladenson PW. A therapeutic controversy. Thyroid hormone treatment when and what?<Emphasis Type="Italic">J Clin Endocrinol Metab.</Emphasis> 1995;80:2873&#8211;2883.</td><td><a href=http://dx.doi.org/10.1210/jc.80.10.2873>10.1210/jc.80.10.2873</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>